Skip to Main Content

Exploring the role of PARG in DNA repair and cancer

Investigating how a novel glycolipid drug kills chemotherapy-resistant ovarian cancer

A new approach to sustained, local, immunotherapy for ovarian cancer

Charting the cellular spacial landscape in rare ovarian cancer

Adapting the Genetics Adviser digital app to support cascade testing

Evaluation of novel parent-of-origin detection sequencing tool

Nova Scotia Ovarian Cancer Biobank

Using population-based data to understand ovarian cancer care and outcomes in Nova Scotia

Ovarian Cancer in Nova Scotian patients: Studying tumour genetics and immune cell interactions over time to unlock new treatment opportunities

Implementation of patient-oriented Folate Receptor Alpha reporting